CRAZX | EARAX | CRAZX / EARAX | |
Total Expense Ratio | 0.81 | 1.13 | 72% |
Annual Report Gross Expense Ratio | 0.81 | 1.24 | 65% |
Fund Existence | 13 years | 14 years | - |
Gain YTD | 12.697 | 9.657 | 131% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 2000 | 1000 | 200% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.5B | 258M | 969% |
Annual Yield % from dividends | 2.26 | 1.92 | 118% |
Returns for 1 year | 10.33 | 7.65 | 135% |
Returns for 3 years | 34.67 | 29.80 | 116% |
Returns for 5 years | 11.49 | 9.27 | 124% |
Returns for 10 years | 36.36 | 34.14 | 106% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HQIAX | 21.73 | 0.13 | +0.60% |
Hartford Equity Income A | |||
FWOAX | 18.47 | 0.07 | +0.38% |
Fidelity Advisor Women's Leadership A | |||
MNBIX | 20.65 | 0.04 | +0.19% |
Manning & Napier Pro-Blend Extnd Term I | |||
PHSZX | 47.23 | -0.06 | -0.13% |
PGIM Jennison Health Sciences Z | |||
MSVEX | 6.19 | -0.01 | -0.16% |
Morgan Stanley Vitality Portfolio A |